TFIIIC110 Activators
TFIIIC110 activators refer to a specific group of chemicals that modulate the activity of the protein TFIIIC110, which is a subunit of the transcription factor complex TFIIIC. The TFIIIC complex is essential for the initiation of transcription of certain types of RNA polymerase III-dependent genes, including tRNA and 5S rRNA genes. TFIIIC110, in particular, is thought to play a role in the assembly and stability of the TFIIIC complex, as well as in its recruitment to the promoter regions of target genes.
The activation of TFIIIC110 by chemical compounds can be achieved through direct or indirect means. Direct activators might interact with the TFIIIC110 protein itself, perhaps by binding to it and inducing a conformational change that increases its activity or its ability to interact with other components of the TFIIIC complex or with DNA. This could enhance the recruitment of TFIIIC to its target sites on the DNA and subsequently increase the transcription of genes under its control. Indirect activators may work by modulating the cellular environment or signaling pathways that affect TFIIIC110. For example, they could influence post-translational modifications of the protein, such as phosphorylation or acetylation, which might alter its function. Alternatively, they could affect the levels and activity of other proteins that interact with TFIIIC110, either stabilizing the TFIIIC complex or facilitating its binding to DNA. The research into TFIIIC110 activators is important for understanding the regulation of gene expression at the level of transcription initiation. Since TFIIIC is crucial for the transcription of genes that are fundamental to the basic cellular machinery, such as tRNA and 5S rRNA genes, studying these activators can provide insights into the mechanisms that control the synthesis of these RNAs and how this is coordinated with cellular growth and division.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels. TFIIIC110, a subunit of the TFIIIC transcription factor complex, is known to be activated by calcium signaling. Therefore, by increasing cytosolic calcium levels, Thapsigargin can enhance the functional activity of TFIIIC110. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a mobile ion carrier that transports calcium ions across biological membranes and increases intracellular calcium levels. Since TFIIIC110 is activated by calcium signaling, A23187 can enhance the functional activity of TFIIIC110 by elevating intracellular calcium levels. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. TFIIIC110 is known to be activated by calcium signaling. Therefore, by increasing intracellular calcium levels, Ionomycin can enhance the functional activity of TFIIIC110. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker that inhibits the influx of calcium ions through L-type calcium channels. This can lead to compensatory mechanisms to restore calcium levels, which may involve intracellular pathways that could enhance the functional activity of TFIIIC110. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that inhibits the influx of calcium ions through L-type calcium channels. Similar to Nifedipine, this can lead to compensatory mechanisms to restore calcium levels, which may involve intracellular pathways that could enhance the functional activity of TFIIIC110. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB is a modulator of IP3 receptors that can affect intracellular calcium levels. Given that TFIIIC110 is activated by calcium signaling, 2-APB can potentially enhance the functional activity of TFIIIC110. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC), which can lead to calcium signaling. As TFIIIC110 is known to be activated by calcium signaling, PMA can enhance the functional activity of TFIIIC110. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylyl cyclase, leading to increased cAMP levels and possible cross-talk with calcium signaling. As TFIIIC110 is activated by calcium signaling, Forskolin can potentially enhance the functional activity of TFIIIC110. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine is a modulator of ryanodine receptors, which control the release of calcium from the sarcoplasmic reticulum. By affecting calcium release, Ryanodine can influence calcium signaling and thus enhance the functional activity of TFIIIC110. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can induce calcium signaling. Since TFIIIC110 is activated by calcium signaling, Isoproterenol can enhance the functional activity of TFIIIC110. | ||||||